Dr. Matthew Overton, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,598 | 74 | 89.4% |
| Education | $188.99 | 2 | 10.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $419.81 | 26 | $0 (2024) |
| Janssen Biotech, Inc. | $359.50 | 10 | $0 (2024) |
| GENZYME CORPORATION | $315.67 | 6 | $0 (2024) |
| UCB, Inc. | $144.47 | 6 | $0 (2024) |
| Lilly USA, LLC | $139.68 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $81.38 | 4 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $58.98 | 3 | $0 (2024) |
| LEO Pharma Inc. | $42.71 | 2 | $0 (2023) |
| PFIZER INC. | $33.53 | 2 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $32.41 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,047 | 50 | ABBVIE INC. ($263.73) |
| 2023 | $204.54 | 9 | ABBVIE INC. ($34.65) |
| 2022 | $322.64 | 8 | GENZYME CORPORATION ($140.23) |
| 2021 | $145.94 | 6 | AbbVie Inc. ($74.53) |
| 2020 | $46.08 | 2 | GENZYME CORPORATION ($28.74) |
| 2019 | $21.21 | 1 | Ortho Dermatologics, a division of Bausch Health US, LLC ($21.21) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $47.07 | General |
| Category: Immunology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.94 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.06 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Dermatology | ||||||
| 10/22/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Immunology | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Immunology | ||||||
| 10/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $31.05 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Immunology | ||||||
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: IMMUNOLOGY | ||||||
| 08/17/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $34.31 | General |
| Category: Immunology | ||||||
| 08/15/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: DERMATOLOGY | ||||||
| 08/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,554 | 3,049 | $192,298 | $120,152 |
| 2022 | 17 | 1,603 | 2,948 | $189,846 | $116,758 |
| 2021 | 17 | 1,305 | 2,227 | $156,940 | $99,001 |
| 2020 | 19 | 1,137 | 2,127 | $117,377 | $72,934 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 335 | 480 | $42,393 | $28,983 | 68.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 228 | 303 | $30,037 | $18,143 | 60.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 163 | 218 | $23,948 | $16,684 | 69.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 234 | 369 | $24,034 | $11,030 | 45.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 114 | $14,130 | $9,897 | 70.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 39 | 42 | $13,116 | $9,449 | 72.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 176 | 1,172 | $7,528 | $5,007 | 66.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 24 | 36 | $6,309 | $4,059 | 64.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 60 | 60 | $6,647 | $3,965 | 59.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 80 | 109 | $5,359 | $3,882 | 72.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 29 | 33 | $8,223 | $2,901 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $4,017 | $2,105 | 52.4% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 18 | 22 | $3,120 | $1,820 | 58.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 40 | $2,167 | $1,566 | 72.3% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 13 | $1,202 | $603.06 | 50.2% |
| 87220 | Tissue fungi or parasites | Office | 2023 | 13 | 14 | $66.50 | $58.52 | 88.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 304 | 413 | $36,881 | $25,536 | 69.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 250 | 299 | $30,052 | $18,122 | 60.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 160 | 203 | $22,765 | $14,874 | 65.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 112 | $13,973 | $9,187 | 65.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 237 | 326 | $21,631 | $9,151 | 42.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 35 | 41 | $12,715 | $8,747 | 68.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 85 | 85 | $9,265 | $5,748 | 62.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 98 | 136 | $6,999 | $5,188 | 74.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 184 | 1,152 | $8,145 | $4,716 | 57.9% |
About Dr. Matthew Overton, M.D
Dr. Matthew Overton, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Concord, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2015. The National Provider Identifier (NPI) number assigned to this provider is 1982091005.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Overton, M.D has received a total of $1,787 in payments from pharmaceutical and medical device companies, with $1,047 received in 2024. These payments were reported across 76 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,598).
As a Medicare-enrolled provider, Overton has provided services to 5,599 Medicare beneficiaries, totaling 10,351 services with total Medicare billing of $408,845. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Dermatology
- Location Concord, NC
- Active Since 04/16/2015
- Last Updated 09/24/2019
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1982091005
Products in Payments
- DUPIXENT (Biological) $345.97
- TREMFYA (Drug) $342.16
- SKYRIZI (Biological) $254.90
- Bimzelx (Biological) $144.47
- TALTZ (Drug) $139.68
- RINVOQ (Biological) $138.60
- Sotyktu (Drug) $62.01
- ADBRY (Biological) $42.71
- Zoryve (Drug) $36.33
- COSENTYX (Drug) $32.00
- Otezla (Drug) $31.05
- HUMIRA (Biological) $26.31
- DUOBRII (Drug) $21.21
- EUCRISA (Drug) $20.72
- OPZELURA (Drug) $19.83
- SPRYCEL (Drug) $19.37
- ILUMYA (Biological) $17.34
- REMICADE (Biological) $17.34
- Winlevi (Drug) $15.07
- TargaDox (Drug) $12.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Concord
Dr. Sherille Sevilla, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $5,528
Dr. Claire Carrazco, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $5,111
Kristina Carpenter, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $3,425
Dr. Lindsay Chong, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $2,188
Dr. Amjad Farah, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $1,639
Caitlin Noble, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $895.26